Investor’s Toolkit: Key Ratios for Assessing Nurix Therapeutics Inc (NRIX)’s Performance

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Nurix Therapeutics Inc (NASDAQ: NRIX) closed the day trading at $22.47 down -2.52% from the previous closing price of $23.05. In other words, the price has decreased by -$2.52 from its previous closing price. On the day, 0.8 million shares were traded. NRIX stock price reached its highest trading level at $24.0 during the session, while it also had its lowest trading level at $22.15.

Ratios:

For a better understanding of NRIX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.57 and its Current Ratio is at 5.57. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.

On July 31, 2024, Truist started tracking the stock assigning a Buy rating and target price of $36.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 03 ’24 when Ring Christine sold 9,050 shares for $24.94 per share. The transaction valued at 225,736 led to the insider holds 24,592 shares of the business.

CHRISTINE RING bought 9,050 shares of NRIX for $228,060 on Sep 03 ’24. On Aug 26 ’24, another insider, Ring Christine, who serves as the Chief Legal Officer of the company, sold 9,870 shares for $25.01 each. As a result, the insider received 246,843 and left with 24,592 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1485354624 and an Enterprise Value of 1033014720. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.23 while its Price-to-Book (P/B) ratio in mrq is 3.90. Its current Enterprise Value per Revenue stands at 16.58 whereas that against EBITDA is -5.997.

Stock Price History:

Over the past 52 weeks, NRIX has reached a high of $26.31, while it has fallen to a 52-week low of $4.22. The 50-Day Moving Average of the stock is -2.54%, while the 200-Day Moving Average is calculated to be 41.00%.

Shares Statistics:

Over the past 3-months, NRIX traded about 714.34K shares per day on average, while over the past 10 days, NRIX traded about 710820 shares per day. A total of 64.41M shares are outstanding, with a floating share count of 63.34M. Insiders hold about 1.67% of the company’s shares, while institutions hold 101.16% stake in the company. Shares short for NRIX as of 1726185600 were 9364663 with a Short Ratio of 13.11, compared to 1723680000 on 9235030. Therefore, it implies a Short% of Shares Outstanding of 9364663 and a Short% of Float of 15.709999999999999.

Most Popular